Sutro Biopharma (STRO) Net Margin (QoQ) (2017 - 2025)

Sutro Biopharma (STRO) Net Margin (QoQ) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sutro Biopharma 202.59 Mn 61.16 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -12,185.00
Sep 30, 2025 -56,854.00
Jun 30, 2025 37,063.00
Mar 31, 2025 10,051.00
Dec 31, 2024 8,344.00
Sep 30, 2024 -38,582.00
Jun 30, 2024 26,072.00
Mar 31, 2024 -47,483.00
Dec 31, 2023 31,852.00
Sep 30, 2023 7,879.00
Jun 30, 2023 2,491.00
Mar 31, 2023 586.00
Dec 31, 2022 -32,327.00
Sep 30, 2022 1,509.00
Jun 30, 2022 57,064.00
Mar 31, 2022 -30,537.00
Dec 31, 2021 498.00
Sep 30, 2021 -34,089.00
Jun 30, 2021 11,224.00
Mar 31, 2021 17,737.00